Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. EXAS.NASDAQ

EXACT Sciences Corporation (EXAS NASDAQ) stock market data APIs

$48.53 3.23(7.1%) as of July 26, 2024
Price chart is built with Anychart

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

EXACT Sciences Corporation Financial Data Overview

45.3
48.53
-
49.36
45.22
40.624-98.885
8 359 M
185 M
2 535 M
1.225
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'EXAS',
Type: 'Common Stock',
Name: 'EXACT Sciences Corporation',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000CWL0F5',
ISIN: NULL,
CUSIP: NULL,
CIK: '1124140',
EmployerIdNumber: '02-0478229',
FiscalYearEnd: 'December',
IPODate: '2001-02-01',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Diagnostics & Research',
HomeCategory: 'Domestic',
IsDelisted: false,
}

EXACT Sciences Corporation Fundamental Data is available in our Financial Data APIs

  • Net Revenue 2 535 M
  • EBITDA -108 443 000
  • Earnings Per Share -1.31
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get EXACT Sciences Corporation Earnings via APIs

  • Latest Release 2024-07-31
  • EPS/Forecast -0.32

Get EXACT Sciences Corporation End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get EXACT Sciences Corporation latest news via APIs

Blueprint Medicines (BPMC) Expected to Beat Earnings Estimates: Should You Buy?

The market expects Blueprint Medicines (BPMC) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2024. This widely-known consensus o...

Exact Sciences (EXAS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

The market expects Exact Sciences (EXAS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2024. This widely-known consensus outloo...
Do you have any questions?
support@eodhistoricaldata.com